SPCX Analyst Ratings

13 ratings from Wall Street analysts · Consensus as of Sep 8, 2026

Analyst Ratings

Buy Avg target $222 showing 13 ratings

Per S&P Global Market Intelligence via StockAnalysis.com (35 analysts, 8 September 2026), consensus is Buy with an average price target of $222.32, a $225 median and a panel spanning $117 to $450. Vendor panels agree on the centre and disagree on the tails: TipRanks (34 analysts) shows $75 to $800 on a $231.21 average and MarketBeat (43, 4 September) $75 to $800 on $221.20. Raymond James holds the $800, initiated 9 July 2026; Morningstar's $62 is a fair value estimate published 16 June 2026, not a sell-side price target, and belongs to none of these panels. The rows below are dated actions and are a selection, not the full panel. The range above is the consensus provider's. Individual analyst actions listed below are sourced separately and can fall outside it. Consensus as of Sep 8, 2026

SPCX

Initiated

2026-09-08

Pivotal Research

RatingBuy

From—

Target$220

From—

Reiterated

2026-09-02

Oppenheimer

RatingOutperform

From—

Target$280

From$250

Reiterated

2026-09-02

Deutsche Bank

RatingBuy

From—

Target$235

From—

Reiterated

2026-09-02

Bank of America Securities

RatingBuy

From—

Target—

From—

Reiterated

2026-09-01

J.P. Morgan

RatingBuy

From—

Target$240

From—

Reiterated

2026-08-31

Sanford C. Bernstein

RatingOutperform

From—

Target—

From—

Reiterated

2026-08-26

Morgan Stanley

RatingOverweight

From—

Target—

From—

Reiterated

2026-08-26

Wolfe Research

RatingOutperform

From—

Target$175

From—

Reiterated

2026-08-13

Citi

RatingBuy

From—

Target—

From—

Reiterated

2026-08-11

Clear Street

RatingBuy

From—

Target$217

From—

Reiterated

2026-08-11

Arete Research

RatingBuy

From—

Target$450

From$401

Initiated

2026-07-09

Raymond James

RatingStrong Buy

From—

Target$800

From—

Initiated

2026-06-12

Morgan Stanley

RatingOverweight

From—

Target$300

From—